UTL-5g
UTL-5g is a novel potential chemoprotective agent, TNF-α inhibitor that reduces cisplatin-induced side effects including nephrotoxicity, hepatotoxicity and hematotoxicity. It lowers elevated levels of AST, ALT, creatinine, BUN, and TNF-α, increases the reduced platelet count in mice, and acts as a novel chemo- and radioprotective agent.
Product Specifications
CAS Number
646530-37-2
Product Name Alternative
3-Isoxazolecarboxamide, N- (2,4-dichlorophenyl) -5-methyl- | GBL-5g
Purity
>98% (HPLC)
Solubility
DMSO:10 mM
Smiles
O=C (C1=NOC (C) =C1) NC2=CC=C (Cl) C=C2Cl
Molecular Formula
C11H8Cl2N2O2
Molecular Weight
271.1
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
P9109-27M-ML550 100 µL
PTPN3 (Protein Tyrosine Phosphatase Non-receptor Type 3, Protein Tyrosine Phosphatase H1, PTP-H1, PTPH1) (MaxLight 550) discontinued
Sign In for Pricing
View Details 
GTR15205776 1 Vial
Lentiviral mouse Loxhd1 shRNA (UAS) - Lentiviral mouse Loxhd1 shRNA (UAS, RFP) (100)
Sign In for Pricing
View Details 
DFC85294-01 50 mg
4- (Difluoromethyl) cyclohexane-1-carboxylic acid
Sign In for Pricing
View Details DFC85294-02 0.5 g
4- (Difluoromethyl) cyclohexane-1-carboxylic acid
Sign In for Pricing
View Details